Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, November 20, 2019
Akcea and Ionis announced the closing of the exclusive licensing agreement with Pfizer for AKCEA-ANGPTL3-LRx.
read more
Wednesday, November 13, 2019
Amneal Pharmaceuticals is voluntarily recalling Ranitidine Tablets, 150 mg and 300 mg, and Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL to the consumer level.
read more
Tuesday, November 12, 2019
Alkermes announced the receipt of a $150 million milestone payment from Biogen triggered by the recent FDA approval of VUMERITY.
read more
Monday, November 11, 2019
American Health Packaging is voluntarily recalling eight lots of Ranitidine Syrup 150 mg/10 mL Liquid Unit Dose Cups to the consumer level.
read more
Monday, November 11, 2019
Samsung Biologics announced the signing of a long-term agreement with Ichnos Sciences for manufacturing drug substance for ISB 830.
read more
Friday, November 08, 2019
IDT Biologika announced the NIAID of the NIH has awarded the company a new Task Order within the 10-year IDIQ to provide process development activities and production of a vaccine against the RSV.
read more
Thursday, November 07, 2019
ANI Pharmaceuticals announced its partner Pii has received FDA approval of a Prior Approval Supplement for Bretylium Tosylate Injection.
read more
Wednesday, November 06, 2019
C2 PHARMA continues to build its active pharmaceutical ingredient (API) and botanical extracts product portfolio.
read more
Wednesday, November 06, 2019
Samsung Bioepis has entered into a new commercialization agreement with Biogen for two biosimilar candidates under development by Samsung Bioepis, SB11 (ranibizumab) and SB15 (aflibercept).
read more
Wednesday, October 30, 2019
The FDA issued a revised final guidance in January 2017, Guidance for Industry, Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act, which is in place while the FDA develops the 503B...
read more
Thursday, October 24, 2019
Vertex announced an access agreement with NHS England for all currently licensed Vertex cystic fibrosis medicines and any future indications of these medicines.
read more
Wednesday, October 23, 2019
The FDA has issued a warning letter to Jiangsu NHWA.
read more
Wednesday, October 16, 2019
CorMedix has completed its interaction with the FDA related to the CMC package that will be needed to support Neutrolin’s NDA.
read more
Tuesday, October 15, 2019
Innoveix Pharmaceuticals is voluntarily recalling all sterile compounded drug products, within expiry, to the consumer level
read more
Tuesday, October 15, 2019
The FDA has posted a warning letter to Torrent Pharmaceuticals in Ahmedabad, Gujarat, India.
read more